SCHEMBL4633100

SCHEMBL4633100

CCCCC/C(C)=C\CC(=O)O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1B1 P15121 1/20 0.54
PPARG P37231 8/20 0.52
PPARD Q03181 8/20 0.52
PPARA Q07869 8/20 0.52
GPR84 Q9NQS5 7/20 0.52
HDAC11 Q96DB2 5/20 0.52
TSHR P16473 4/20 0.52
PTPN1 P18031 4/20 0.52
FABP4 P15090 4/20 0.52
HSD17B10 Q99714 3/20 0.52
ALDH1A1 P00352 2/20 0.52
TLR2 O60603 2/20 0.52
TDP1 Q9NUW8 2/20 0.52
ALOX15 P16050 2/20 0.52
KMT2A Q03164 2/20 0.52
FABP5 Q01469 2/20 0.52
SLC22A6 Q4U2R8 1/20 0.52
SLC22A8 Q8TCC7 1/20 0.52
MEN1 O00255 1/20 0.52
ESR1 P03372 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4633104 1.00 AKR1B1 (0.54) AKR1B1PPARGPPARDPPARAGPR84
SCHEMBL4922927 1.00 AKR1B1 (0.54) AKR1B1PPARGPPARDPPARAGPR84
SCHEMBL7057634 0.98 GPR84 (0.56) AKR1B1PPARGPPARDPPARAGPR84
SCHEMBL7057637 0.98 GPR84 (0.56) AKR1B1PPARGPPARDPPARAGPR84
SCHEMBL4633389 0.94 AKR1B1 (0.44) AKR1B1PPARGPPARDPPARAGPR84
SCHEMBL4632408 0.94 AKR1B1 (0.44) AKR1B1PPARGPPARDPPARAGPR84
SCHEMBL4632410 0.94 AKR1B1 (0.44) AKR1B1PPARGPPARDPPARAGPR84
SCHEMBL21176641 0.85 FFAR3 (0.48) AKR1B1PPARGPPARDPPARAGPR84
SCHEMBL11055349 0.85 FFAR3 (0.48) AKR1B1PPARGPPARDPPARAGPR84
SCHEMBL11884463 0.81 AKR1B1 (0.56) AKR1B1PPARGPPARDPPARAGPR84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080260670-A1 Organic Compounds GIVAUDAN SA (CH) 2008-10-23 US disclosed
EP-1926531-A2 ORGANIC COMPOUNDS Givaudan SA (CH) 2008-06-04 EP disclosed
WO-2007033508-A2 ORGANIC COMPOUNDS GIVAUDAN SA (CH) 2007-03-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080260670-A1 Organic Compounds OR10J3, OR51E2, ELOVL1 AKR1B1 945/4885PPARG 635/4885PPARD 695/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.